InChI=1S/C26H33NO9/c1-12(7-8-16(28)19-18(30)11-27-23(19)31)9-13(2)21-14(3)22-17(29)10-25(5)26(35-21,36-22)20(15(4)34-25)24(32)33-6/h7-9,13-15,20-22,28H,10-11H2,1-6H3,(H,27,31)/p-1/b8-7+,12-9+,19-16+/t13-,14-,15-,20-,21-,22+,25+,26+/m1/s1 |
DTURANKMSHIDDI-GMYASLLUSA-M |
[C@]12([C@@H]([C@](O[C@]3(O1)[C@H]([C@H](O[C@]3(CC2=O)C)C)C(=O)OC)([C@H](C)/C=C(\C)/C=C/C(=C/4\C(NCC4=O)=O)/[O-])[H])C)[H] |
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
|
|
View more via ChEBI Ontology
(1E,2E,4E,6R)-1-(2,4-dioxopyrrolidin-3-ylidene)-6-[(2R,3S,3aS,5R,6R,7S,9aS)-3-(methoxycarbonyl)-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocin-5-yl]-4-methylhepta-2,4-dien-1-olate
|
(−)-nocamycin I(1−)
|
ChEBI
|
Antibiotic BU 2313B(1−)
|
ChEBI
|
BU 2313B(1−)
|
ChEBI
|
Bu-2313B(1−)
|
ChEBI
|
methyl (1S,2S,3R,5S,8S,9R,10R)-10-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-4-methyl-7-oxidohepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate
|
IUPAC
|
nocamycin I
|
UniProt
|
28818448
|
PubMed citation
|
SUBMITTER
|
6920296
|
PubMed citation
|
Europe PMC
|
|